Getting An Extra Shot On Life: Drinking Coffee Found To Lengthen Life In Major Study

Go ahead and have a second cup of Joe this morning . . . you might live longer. A study published in the New England Journal of Medicine found that both men and women lived longer on average if they drank two or three cups of coffee a day. No, the study was not funded by Starbucks.

What I thought was most interesting is that it did not change between caffeinated or decaffeinated coffee. For men, the difference was a ten percent advantage while for women it was a thirteen percent advantage.

The study was done by researchers at the National Cancer Institute. Here is another interesting fact. Americans drank 77.4 billion cups from June 30, 2011 to June 30, 2012 — roughly 64 percent of U.S. adults drink coffee every day while 73 percent drink it weekly.

The study itself was huge with more than 402,000 men and women participating.

My only question is when my HMO will cover my Starbuck’s Latte.

Source: Bloomberg

25 thoughts on “Getting An Extra Shot On Life: Drinking Coffee Found To Lengthen Life In Major Study”

  1. Zune and iPod: Most people compare the Zune to the Touch, but after seeing how slim and surprisingly small and light it is, I consider it to be a rather unique hybrid that combines qualities of both the Touch and the Nano. It’s very colorful and lovely OLED screen is slightly smaller than the touch screen, but the player itself feels quite a bit smaller and lighter. It weighs about 2/3 as much, and is noticeably smaller in width and height, while being just a hair thicker

  2. What a nice day it is!He goes home early everyday for fear that his wife would be angry.His father runs a restaurant.The meeting was scheduled for two hours, but it is now over yetI’m sorry to have bothered you.It seemed as if there was no way out.He is ill in bed.There’ll be some sport reviews on TV.The sun comes up in the east.How long have you been here?

  3. Visit this site below if you need driver?

    laptop-driver.blogspot dot com

Comments are closed.